A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches

A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches

Abstract Background Glioblastoma multiforme (GBM) is a lethal brain tumor. With the current gold standard chemotherapy treatment, temozolomide (TMZ), many patients do not survive beyond one year. While the urgency of researching novel treatments is understandable, the prohibitively high costs and th...

Full description

Saved in:
Bibliographic Details
Main Authors: Meijun Liu, Yuying Wang, Xiaoli Chen, Yu Zeng, Wenqiong Huang, Jiawen Yang, Hong Dai, Lixin Cheng, Claudio Mauro, Kenneth Chat Pan Cheung
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Clinical Epigenetics
Subjects:
Glioblastoma multiforme
Temozolomide
Disulfiram
Cuproptosis
Aspirin
Non-coding RNA
Online Access:https://doi.org/10.1186/s13148-025-01900-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13148-025-01900-5

Similar Items